Using brain imaging technology, researchers at the University of Nottingham, United Kingdom, are working on a way to develop biomarkers for ataxia-telangiectasia that may enable and accelerate future clinical trials. Biomarkers are indirect measures of the underlying disease process that can help to assess whether or not drugs work.

Drs. Robert Dineen and Dorothee Auer at the University of Nottingham are aiming to develop biomarkers for A-T using modern imaging techniques. They are recruiting 30 patients from the United Kingdom National A-T Clinic and 20 age-matched people without A-T (controls). These individuals will undergo advanced magnetic resonance imaging. If the researchers find differences between the two groups that are significant, the results will be validated. Then, the new biomarkers can be used during future clinical trials to measure whether the therapy being tested is effective.

Several A-T organizations have been working together to make this research grant happen. The idea for the project stems directly from an A-T clinical research conference held by the A-T Society in the UK, and it is being funded jointly by the A-T Children’s Project and Action for A-T, also in the UK.

Contact Us

Related News

Feb 16 @ 1:32 pm

Gene Editing for A-T Grant Awarded

We are pleased to announce that funds have been awarded to a researcher with Johns Hopkins University.

more
Feb 16 @ 1:32 pm

2025 Could Be a Landmark Year for A-T Research

We’re feeling so optimistic about the new year, given the accelerated progress we’re seeing in our search for

more
Feb 16 @ 1:32 pm

Encouraging Initial Results from an A-T Drug Repurposing Screen

We’re thrilled to share encouraging initial results from a study funded by the A-T Children’s Project and conducted

more
Feb 16 @ 1:32 pm

Jehlik Family Matched Giving Tuesday Donations for A-T

The Jeff Jehlik Memorial Fund Will Match Your "Giving Tuesday" Donation for A-T up to $100,000!

more